ELVN
Enliven Therapeutics, Inc.
$50.87
-0.22 (-0.43%)
At close · Jul 13
Market Cap
$3.10B
Shares
60,904,946
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
82/100
Short interest 14.0% of shares — P94
Days to cover 3.1 — P61
Price vs VWAP +13.9% — P91
Short-volume trend +7.5% — P77
Short interest change +57.1% — P89
Worst FTD 0.05% of shares — P73
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 8,527,025 | 5,426,405 | +3,100,620 | 3.09 |
| 2026-06-15 | 5,426,405 | 5,213,383 | +213,022 | 2.61 |
| 2026-05-29 | 5,213,383 | 5,122,350 | +91,033 | 8.73 |
| 2026-05-15 | 5,122,350 | 5,273,791 | -151,441 | 8.05 |
| 2026-04-30 | 5,273,791 | 5,374,014 | -100,223 | 6.86 |
| 2026-04-15 | 5,374,014 | 6,053,456 | -679,442 | 4.28 |
| 2026-03-31 | 6,053,456 | 8,215,500 | -2,162,044 | 2.86 |
| 2026-03-13 | 8,215,500 | 7,979,674 | +235,826 | 10.54 |
| 2026-02-27 | 7,979,674 | 8,078,549 | -98,875 | 12.26 |
| 2026-02-13 | 8,078,549 | 7,870,182 | +208,367 | 11.21 |
| 2026-01-30 | 7,870,182 | 9,166,736 | -1,296,554 | 7.89 |
| 2026-01-15 | 9,166,736 | 8,312,949 | +853,787 | 4.19 |
| 2025-12-31 | 8,312,949 | 8,111,262 | +201,687 | 11.85 |
| 2025-12-15 | 8,111,262 | 7,996,827 | +114,435 | 9.81 |
| 2025-11-28 | 7,996,827 | 7,794,126 | +202,701 | 14.74 |
| 2025-11-14 | 7,794,126 | 7,782,638 | +11,488 | 10.37 |
| 2025-10-31 | 7,782,638 | 6,422,840 | +1,359,798 | 18.19 |
| 2025-10-15 | 6,422,840 | 5,699,585 | +723,255 | 15.53 |
| 2025-09-30 | 5,699,585 | 4,856,687 | +842,898 | 8.22 |
| 2025-09-15 | 4,856,687 | 4,891,510 | -34,823 | 10.19 |
| 2025-08-29 | 4,891,510 | 4,944,385 | -52,875 | 10.30 |
| 2025-08-15 | 4,944,385 | 5,076,202 | -131,817 | 13.11 |
| 2025-07-31 | 5,076,202 | 5,543,837 | -467,635 | 15.31 |
| 2025-07-15 | 5,543,837 | 6,133,570 | -589,733 | 9.95 |
Showing 1–24 of 24 settlements
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
11 filings
10 filers
Visit website
Investor relations